Risks of All‐Cause Mortality in Adults With Chronic Kidney Disease With Sarcopenia or Obesity: A Population‐Based Study
Journal of Cachexia, Sarcopenia and Muscle · 2025-06 · 16 (3)
DOI: 10.1002/jcsm.13828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 05.06.2025. Verfasst von Jin'e Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Sarcopenia, Renal Insufficiency, Chronic, Obesity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Jiangxi Province, Graduate innovation project of Jiangxi Province.
Abstract (Originalsprache)
Background
The relationship between obesity, sarcopenic obesity and all‐cause mortality in chronic kidney disease (CKD) patients remains controversial. This study aims to investigate the role of low muscle mass and fat mass in the risk of all‐cause mortality in CKD patients in the United States.
Methods
This study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted between 1999–2006 and 2011–2018, including 1553 adults with CKD. Multivariable Cox proportional hazards models were constructed to explore the relationship between sarcopenia, fat mass and all‐cause mortality, with nonlinear relationships assessed using restricted cubic splines. Subgroup analyses were conducted based on sex, CKD stages and the presence of sarcopenia.
Results
The average age of participants was 58.15 ± 18.48 years, with 45% being male. Sarcopenia was more common in men, non‐diabetic individuals and those with lower education levels. During a median follow‐up of 119.5 months, 693 deaths from all causes were recorded. After adjusting for multiple variables, sarcopenia was significantly associated with increased all‐cause mortality risk in CKD patients (HR 1.21; 95% CI 1.00–1.45, p = 0.047). Participants were categorized based on body mass index (BMI) into normal (reference), sarcopenia only, obesity only and sarcopenic obesity groups. Results showed that obesity alone had a protective effect in CKD Stages I–II (HR 0.45, 95% CI 0.28–0.72, p = 0.001) whereas it had an opposite effect in CKD Stages III–V (CKD III: HR 1.67, 95% CI 1.07–2.60, p = 0.024; CKD IV–V: HR 17.51, 95% CI 1.29–238.01, p = 0.032). Further analysis of fat mass data revealed that compared with the lowest quartile (Q1), middle and higher quartiles of fat mass showed significant benefits in male participants (Q2: HR 0.71, 95% CI 0.51–0.99, p = 0.046; Q3: HR 0.62, 95% CI 0.41–0.92, p = 0.019) and those in CKD Stage III (Q2: HR 0.64, 95% CI 0.47–0.88, p = 0.006; Q3: HR 0.62, 95% CI 0.41–0.93, p = 0.021).
Conclusions
In this longitudinal cohort study, we found that sarcopenia was associated with an increased risk of all‐cause mortality in CKD patients, whereas moderate or higher fat mass might mitigate this risk, particularly in male patients. Prognostic management for CKD patients should focus on increasing muscle mass rather than simply reducing body weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Institute for the Study of Endocrinology and Metabolism in Jiangxi Province, Nanchang, Jiangxi, China.
- Jiangxi Key Laboratory of Molecular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Jiangxi Province
- Graduate innovation project of Jiangxi Province
- Project of the Second Affiliated Hospital of Nanchang University
- Jiangxi Province Key Laboratory of Molecular Medicine
Zitieren
APA
Li, J., Tu, H., Zhang, Y., Yang, S., Yu, P., & Liu, J. (2025). Risks of All‐Cause Mortality in Adults With Chronic Kidney Disease With Sarcopenia or Obesity: A Population‐Based Study. Journal of Cachexia, Sarcopenia and Muscle, 16(3). https://doi.org/10.1002/jcsm.13828
Vancouver
Li J, Tu H, Zhang Y, Yang S, Yu P, Liu J. Risks of All‐Cause Mortality in Adults With Chronic Kidney Disease With Sarcopenia or Obesity: A Population‐Based Study. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(3). doi:10.1002/jcsm.13828
BibTeX
@article{Li2025,
author = {Li, Jin'e and Tu, Hua and Zhang, Yuying and Yang, Shiqi and Yu, Peng and Liu, Jianping},
title = {Risks of All‐Cause Mortality in Adults With Chronic Kidney Disease With Sarcopenia or Obesity: A Population‐Based Study},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
volume = {16},
number = {3},
doi = {10.1002/jcsm.13828}
}
EUVIMED